Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of All Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets Due to Potential Presence of N-nitrosoirbesartan Impurity


Baltimore, Maryland, October 14, 2021: Lupin Pharmaceuticals Inc. is voluntarily recalling the below-mentioned batches of Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets to the consumer level. As part of Lupin’s ongoing assessment, analysis revealed that certain tested API batches (US Food Recalls) More More

Similar stories

An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine ... - ScienceDirect.com

An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine ...  ScienceDirect.com

Posted on 24 December 2022 | 4:29 am | Google News

Antihypertensive Meds Recalled Due to Nitrosamine Impurity - Monthly Prescribing Reference

Antihypertensive Meds Recalled Due to Nitrosamine Impurity  Monthly Prescribing Reference

Posted on 14 October 2021 | 2:00 am | Google News

Copyright © 2024 LastMinuteStuff.com | Contact info